Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Cyclacel Pharma Enters into Co-Development Agreement with University of Texas MD Anderson Cancer Center 11
Licensing Agreements 12
Cyclacel Enters into Licensing Agreement with ManRos Therapeutics 12
Equity Offering 13
Cyclacel Pharma to Raise up to USD5 Million in Public Offering of Shares 13
Cyclacel Pharma Raises USD15.2 Million in Public Offering of Units 14
Cyclacel Pharma Raises USD1 Million in Public Offering of Shares 16
Cyclacel Pharma Raises USD2.8 Million in Private Placement of Shares 17
Cyclacel Pharma to Raise up to USD8.35 Million in Private Placement of Shares 18
Cyclacel Pharma Raises USD10 Million in Public Offering of Shares 19
Cyclacel Pharma Completes Public Offering Of Shares For US$10 Million 21
Cyclacel Pharma Completes Public Offering Of Shares For US$20 Million 23
Cyclacel Pharma Completes Private Placement Of Shares For US$3 Million 25
Asset Transactions 26
Celgene To Acquire Romidepsin Injection Patents From Cyclacel For US$5.5 Million 26
Cyclacel Pharmaceuticals Inc – Key Competitors 28
Cyclacel Pharmaceuticals Inc – Key Employees 29
Cyclacel Pharmaceuticals Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Aug 09, 2018: Cyclacel Pharmaceuticals reports second quarter 2018 financial results 31
May 14, 2018: Cyclacel Pharmaceuticals Announces First Quarter 2018 Financial Results 33
Mar 28, 2018: Cyclacel Pharmaceuticals Announces Fourth Quarter And Full Year 2017 Financial Results 35
Nov 09, 2017: Cyclacel Pharmaceuticals Reports Third Quarter 2017 Financial Results 38
Aug 09, 2017: Cyclacel Pharmaceuticals Reports Second Quarter 2017 Financial Results 40
May 11, 2017: Cyclacel Pharmaceuticals Reports First Quarter 2017 Financial Results 42
Mar 28, 2017: Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results 44
Corporate Communications 46
Sep 12, 2018: Cyclacel Pharmaceuticals names Robert J. Spiegel as Board Director 46
May 22, 2018: CerSci Therapeutics Names Dr. David U’Prichard To Advisory Board 47
Product News 48
09/11/2018: Cyclacel starts Phase lb/ll trial BRCA mutant breast cancer 48
Clinical Trials 49
Feb 21, 2018: Cyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical Formulations 49
Dec 12, 2017: Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting 50
Nov 01, 2017: Cyclacel Pharmaceuticals Announces That Full Results From the Phase 3 Seamless Trial Have Been Selected for Oral Presentation at ASH 2017 Annual Meeting 52
Apr 02, 2017: Cyclacel’s Second-Generation CDK2/9 Inhibitor, CYC065, Elicits Marked Antineoplastic Effects in Lung Cancer by Engaging Anti-Metastatic Pathways 53
Mar 07, 2017: Cyclacels CDK Inhibitor CYC065 Causes Anaphase Catastrophe, a Novel Cancer-Specific Mechanism of Action, in Research Published in JNCI 55
Feb 23, 2017: Cyclacel Announces Top-Line Results From Pivotal Phase 3 SEAMLESS Study in Elderly Patients With Acute Myeloid Leukemia 56
Other Significant Developments 58
Jan 09, 2018: Cyclacel Reviews 2017 Achievements and Announces Key Business Objectives for 2018 58
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cyclacel Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cyclacel Pharma Enters into Co-Development Agreement with University of Texas MD Anderson Cancer Center 11
Cyclacel Enters into Licensing Agreement with ManRos Therapeutics 12
Cyclacel Pharma to Raise up to USD5 Million in Public Offering of Shares 13
Cyclacel Pharma Raises USD15.2 Million in Public Offering of Units 14
Cyclacel Pharma Raises USD1 Million in Public Offering of Shares 16
Cyclacel Pharma Raises USD2.8 Million in Private Placement of Shares 17
Cyclacel Pharma to Raise up to USD8.35 Million in Private Placement of Shares 18
Cyclacel Pharma Raises USD10 Million in Public Offering of Shares 19
Cyclacel Pharma Completes Public Offering Of Shares For US$10 Million 21
Cyclacel Pharma Completes Public Offering Of Shares For US$20 Million 23
Cyclacel Pharma Completes Private Placement Of Shares For US$3 Million 25
Celgene To Acquire Romidepsin Injection Patents From Cyclacel For US$5.5 Million 26
Cyclacel Pharmaceuticals Inc, Key Competitors 28
Cyclacel Pharmaceuticals Inc, Key Employees 29
Cyclacel Pharmaceuticals Inc, Other Locations 30
Cyclacel Pharmaceuticals Inc, Subsidiaries 30
List of Figures
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9